Found: 14
Select item for more details and to access through your institution.
Serendipitous Identification of Azine Anticancer Agents Using a Privileged Scaffold Morphing Strategy.
- Published in:
- Molecules, 2024, v. 29, n. 7, p. 1452, doi. 10.3390/molecules29071452
- By:
- Publication type:
- Article
Privileged Scaffold Decoration for the Identification of the First Trisubstituted Triazine with Anti-SARS-CoV-2 Activity.
- Published in:
- Molecules, 2022, v. 27, n. 24, p. 8829, doi. 10.3390/molecules27248829
- By:
- Publication type:
- Article
In vitro susceptibility of HIV-1 CRF02_AG to temsavir, the active compound of the attachment inhibitor fostemsavir.
- Published in:
- 2021
- By:
- Publication type:
- letter
In vitro cross-resistance to doravirine in a panel of HIV-1 clones harbouring multiple NNRTI resistance mutations.
- Published in:
- 2021
- By:
- Publication type:
- journal article
In vitro susceptibility to fostemsavir is not affected by long-term exposure to antiviral therapy in MDR HIV-1-infected patients.
- Published in:
- 2020
- By:
- Publication type:
- journal article
In Vitro Combinatorial Activity of Direct Acting Antivirals and Monoclonal Antibodies against the Ancestral B.1 and BQ.1.1 SARS-CoV-2 Viral Variants.
- Published in:
- Viruses (1999-4915), 2024, v. 16, n. 2, p. 168, doi. 10.3390/v16020168
- By:
- Publication type:
- Article
Efficacy of Licensed Monoclonal Antibodies and Antiviral Agents against the SARS-CoV-2 Omicron Sublineages BA.1 and BA.2.
- Published in:
- Viruses (1999-4915), 2022, v. 14, n. 7, p. N.PAG, doi. 10.3390/v14071374
- By:
- Publication type:
- Article
Long-Term Longitudinal Analysis of Neutralizing Antibody Response to Three Vaccine Doses in a Real-Life Setting of Previously SARS-CoV-2 Infected Healthcare Workers: A Model for Predicting Response to Further Vaccine Doses.
- Published in:
- Vaccines, 2022, v. 10, n. 8, p. 1237, doi. 10.3390/vaccines10081237
- By:
- Publication type:
- Article
Prevalence and Phenotypic Susceptibility to Doravirine of the HIV-1 Reverse Transcriptase V106I Polymorphism in B and Non-B Subtypes.
- Published in:
- Journal of Infectious Diseases, 2024, v. 229, n. 6, p. 1796, doi. 10.1093/infdis/jiae010
- By:
- Publication type:
- Article
Broad synergistic antiviral efficacy between a novel elite controller-derived dipeptide and antiretrovirals against drug-resistant HIV-1.
- Published in:
- Frontiers in Cellular & Infection Microbiology, 2024, p. 1, doi. 10.3389/fcimb.2024.1334126
- By:
- Publication type:
- Article
Nucleoside Derivatives of 2,6‐Diaminopurine Antivirals: Base‐Modified Nucleosides with Broad‐Spectrum Antimicrobial Properties.
- Published in:
- ChemMedChem, 2023, v. 18, n. 16, p. 1, doi. 10.1002/cmdc.202300200
- By:
- Publication type:
- Article
Sofosbuvir Selects for Drug-Resistant Amino Acid Variants in the Zika Virus RNA-Dependent RNA-Polymerase Complex In Vitro.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 5, p. 2670, doi. 10.3390/ijms22052670
- By:
- Publication type:
- Article
Regaining virological suppression in a woman living with a six‐class resistant HIV by combining injectable antiretroviral drugs guided by genotypic and phenotypic tests.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
HIV-1 Integrase Inhibition Activity by Spiroketals Derived from Plagius flosculosus , an Endemic Plant of Sardinia (Italy) and Corsica (France).
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 8, p. 1118, doi. 10.3390/ph16081118
- By:
- Publication type:
- Article